Location preference

Enter your country so we can show you products that are available for you.

father with son

Transfusion Therapies

Understand types of transfusion therapies

Learn about three types of transfusion therapies that can help you manage your sickle cell disease and related complications.

The three types of therapies

You receive a transfusion of red blood cells from a healthy donor, but none of your own blood is removed.

What to expect during the procedure

Before the procedure: A nurse connects a blood bag containing healthy donor red blood cells to your arm through a needle.

During the procedure: The healthy donor red blood cells flow from the bag to your body. This requires approximately 1 to 3 units of red blood cells.

During this procedure, a nurse accesses one of your veins with a needle and removes a small portion of your whole blood, which contains plasma, platelets, red blood cells, and white blood cells. Then a small amount of healthy red blood cells is transfused. This type of exchange is considered "manual" because an automated medical device is not required.

What to expect during the procedure

Before the procedureA nurse connects one vein, usually in the arm, to an empty blood bag using a needle. Another vein, usually in the opposite arm, is connected to a bag full of healthy donor red blood cells with another needle.

During the procedure: The nurse draws a small amount of your whole blood, which flows into the empty blood bag. Then the nurse transfuses a small portion of healthy red blood cells to you. These two steps are repeated until the desired outcomes are achieved.

Manual exchange requires approximately 1 to 3 units of red blood cells.

This type of exchange transfusion rapidly removes your red blood cells and replaces them with healthy donor red blood cells using an apheresis device. Not all hospitals have access to this device. This exchange transfusion requires a specialized team of trained clinicians and operators.

What to expect during the procedure

Before the procedureA single-use sterile tube is connected to your veins through a needle, usually in one or both of your arms. A clinician may decide that a more permanent kind of access connection is needed.

During the procedure: A small portion of your blood is removed and mixed with a fluid that prevents the blood from clotting. The apheresis device spins the blood in a centrifuge to separate it into red blood cells, white blood cells, platelets, and plasma. At any point during the procedure, the amount of blood in the tubing set is less than the amount of cola in a can.

Your red blood cells flow to a waste bag, and healthy donor red blood cells are returned to you along with your white blood cells, platelets, and plasma.

An RBCX procedure requires approximately 3 to 9 units of red blood cells.


How often would you need to receive the therapy?

Average procedure frequency
Simple transfusion

Once every 2 to 3 weeks¹

Manual exchange

Once every 3 to 4 weeks²˒³

Automated RBCX

Once every 4 to 6 weeks²˒³

How long does each transfusion therapy procedure take?

Average procedure time
Simple transfusion

3 to 6 hours⁴˒⁵

Manual exchange

2 to 4 hours²˒³˒⁴˒⁶

Automated RBCX

1.5 to 2 hours²˒³˒⁴˒⁵˒⁶

What is vascular access, and what kind would you need?

To provide transfusion therapy, your clinician needs access to your bloodstream. This is called vascular access or venous access, and there are several types. Peripheral venous access means that one or two needles are placed in your hand(s) or arm(s). Simple transfusion, manual exchange, and automated RBCX can all be done via peripheral access in some patients.

Sometimes, a specialist will determine that they cannot access your peripheral veins and will need to place a more permanent type of vascular access device in a central vein instead of in your hand or arm.

Side effects of automated red blood cell exchange (RBCX) may include: 
Anxiety, headache, light-headedness, digital and/or facial paresthesia (tingling sensation in the arms, hands, feet, legs, or face), fever, chills, hematoma, hyperventilation, nausea and vomiting, syncope (fainting), urticaria (hives), hypotension, allergic reactions, infection, hemolysis, thrombosis in patient and device, hypocalcemia, hypokalemia, thrombocytopenia, hypoalbuminemia, anemia, coagulopathy, fatigue, hypomagnesemia, hypogammaglobulinemia, adverse tissue reaction, device failure/disposable set failure, air embolism, blood loss/anemia, electrical shock, fluid imbalance, and inadequate separation of blood components.⁷
 
Contraindications 
Automated RBCX may not be an option for all patients with sickle cell disease. Talk to your physician about your transfusion options. Contraindications for the use of apheresis systems are limited to those associated with the infusion of solutions and replacement fluids as required by the apheresis procedure and those associated with all types of automated apheresis systems. 
 
Reactions to blood products transfused during procedures can include: 
Hemolytic transfusion reaction, immune-mediated platelet destruction, fever, allergic reactions, anaphylaxis, transfusion-related acute lung injury (TRALI), alloimmunization, posttransfusion purpura (PTP), transfusion-associated graft-versus-host disease (TA-GVHD), circulatory overload, hypothermia, metabolic complications, and transmission of infectious diseases and bacteria.⁸˒⁹ 

Restricted to prescription use only. 
Operators must be familiar with the system’s operating instructions.
Procedures must be performed by qualified medical personnel.


Disclaimers and notes

  1. Howard J. The role of blood transfusion in sickle cell disease. ISBT Science Series. 2013;8:225-228.
  2. Dedeken L, Le PQ, Rozen L, et al. Automated red blood cell exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload. Transfusion. 2018;58(6):1356-1362.
  3. Kuo K, Ward R, Kaya B, Howard J, Telfer P. A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients. Br J Haematol. 2015;170(3):425-428.
  4. National Institute for Health and Care Excellence (NICE). Spectra Optia for automatic red blood cell exchange in patients with sickle cell disease. https://www.nice.org.uk/guidance/mtg28/chapter/5-Cost-considerations. Accessed November 2020.
  5. Singer T, Quirolo K, Nishi K, Hackney-Stephens E, Evans C, Vichinsky E. Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low HbS level and reducing iron overload. J Clin Apher. 1999;14(3):122-125.World Health Organization (WHO). Fifty-ninth world health assembly. Sickle-cell anaemia: report by the Secretariat. https://who.int. Published April 24, 2006. Accessed June 1, 2020.
  6. Duclos C, Merlin E, Paillard C, et al. Long-term red blood cell exchange in children with sickle cell disease: manual or automatic? Transfus Apher Sci. 2013;48(2):219-222.
  7. Crookston KP. Therapeutic Apheresis: a Physician’s Handbook. 5th ed. Bethesda, MD: AABB/ASFA; 2017.
  8. AABB. Circular of Information for the Use of Human Blood and Blood Components. Bethesda, MD: AABB; 2017.
  9. European Directorate for the Quality of Medicines & HealthCare (EDQM). Guide to the Preparation, Use and Quality Assurance of Blood Components. 20th ed. Strasbourg, France: EDQM Council of Europe; 2020.
To top